Fidson Pharmaceuticals Secures Global License to Produce Generic Influenza Antiviral
Fidson Pharmaceuticals has been chosen to manufacture a generic influenza antiviral as part of a global initiative aimed at increasing access to essential medicines. This development positions Nigeria among a select group of countries participating in a worldwide health effort to combat influenza outbreaks.














